Skip to main content Skip to main navigation menu Skip to site footer

Colonization of Citrobacter koseri and Streptococcus agalactiae in a case of cellulitis cruris dextra et sinistra

  • Luh Gede Melia Puspita Sari ,
  • Ni Nengah Dwi Fatmawati ,
  • I Gusti Ayu Agung Praharsini ,
  • Marvin Giantoro ,

Abstract

Background: Cellulitis is a skin infection involving the deep dermis and subcutaneous tissue, characterized by localized pain, swelling, tenderness, erythema, and warmth. The most common causes of cellulitis are group A streptococci and Staphylococcus aureus. Streptococcus agalactiae or the so-called group B Streptococcus can also cause cellulitis. This case report aims to evaluate the colonization of Citrobacter koseri and Streptococcus agalactiae in a case of cellulitis cruris dextra et sinistra.

Case Presentation: A 53-year-old married woman presented to the outpatient clinic complaining of swelling and redness in her left and right legs since five days ago. At first, there was only a little redness around the calf, but it became wider and pain in that area. On examination, there were multiple erythematous macules, patches, and multiple erosional lesions, warm palpable and tender to palpation, and the diascopy test disappeared with pressure. Based on the wound culture results, isolated Citrobacter koseri and Streptococcus agalactiae bacteria were considered colonization. Both of these bacteria were less virulent. The patient was treated with systemic and topical antibiotics, analgesics, wound care management and elevated lower limbs.

Conclusion: The diagnosis of cellulitis is based on history and physical examination. On examination of the wound culture of this case, Citrobacter koseri and Streptococcus agalactiae were found, considered as colonization. The patient showed clinical improvement at each observation after administration of antibiotics and wound care management. The patient's prognosis is dubious ad bonam.

References

  1. Raff AB, Kroshinsky D. Cellulitis: A Review. JAMA. 2016;316(3):325-337.
  2. Rrapi R, Chand S, Kroshinsky D. Cellulitis: A Review of Pathogenesis, Diagnosis, and Management. Med Clin North Am. 2021;105(4):723-735.
  3. Bystritsky RJ. Cellulitis. Infect Dis Clin North Am. 2021;35(1):49-60.
  4. Ellis Simonsen SM, van Orman ER, Hatch BE, et al. Cellulitis incidence in a defined population. Epidemiol Infect. 2006;134(2):293-299.
  5. Departemen Kesehatan RI. Profil Kesehatan Indonesia Tahun 2009. Departemen Kesehatan Republik Indonesia. 2010.
  6. RSUP Sanglah. Buku register rawat inap kulit dan kelamin. Rumah Sakit Umum Pusat Sanglah Denpasar. Desember 2016 – Juni 2020. 2020.
  7. Bailey E, Kroshinsky D. Cellulitis: diagnosis and management. Dermatol Ther. 2011;24(2):229-239.
  8. Raabe VN, Shane AL. Group B Streptococcus(Streptococcus agalactiae). Microbiol Spectr. 2019;7(2):10.1128/microbiolspec.GPP3-0007-2018.
  9. Rodriguez JR, Hsieh F, Huang CT, Tsai TJ, Chen C, Cheng MH. Clinical features, microbiological epidemiology and recommendations for management of cellulitis in extremity lymphedema. J Surg Oncol. 2020;121(1):25-36.
  10. Lederman ER, Weld LH, Elyazar IR, von Sonnenburg F, Loutan L, Schwartz E, Keystone JS; GeoSentinel Surveillance Network. Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int J Infect Dis. 2008;12(6):593-602.
  11. Brindle RJ, O'Neill LA, Williams OM. Risk, Prevention, Diagnosis, and Management of Cellulitis and Erysipelas. Curr Dermatol Rep. 2020;9(1):73–82.
  12. Sullivan T, de Barra E. Diagnosis and management of cellulitis. Clin Med (Lond). 2018;18(2):160-163.
  13. Bystritsky R, Chambers H. Cellulitis and Soft Tissue Infections. Ann Intern Med. 2018;168(3):ITC17-ITC32.
  14. Wyllie DH, Bowler IC, Peto TE. Relation between lymphopenia and bacteraemia in UK adults with medical emergencies. J Clin Pathol. 2004;57(9):950-955.
  15. Cranendonk DR, Hugenholtz F, Prins JM, Savelkoul PHM, Budding AE, Wiersinga WJ et al. The Skin Microbiota in Patients Hospitalized for Cellulitis and Association With Outcome. Clin Infect Dis. 2019;68(8):1292-1299.
  16. Paveenkittiporn W, Ungcharoen R, Kerdsin A. Streptococcus agalactiae infections and clinical relevance in adults, Thailand. Diagn Microbiol Infect Dis. 2020;97(1):115005.
  17. Shabayek S, Spellerberg B. Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology. Front Microbiol. 2018;9:437.
  18. Pyclik M, Górska S, Brzozowska E, Dobrut A, Ciekot J, Gamian A, et al. Epitope Mapping of Streptococcus agalactiaeElongation Factor Tu Protein Recognized by Human Sera. Front Microbiol. 2018;9:125.
  19. Yuan C, Yin Z, Wang J, Qian C, Wei Y, Zhang S, et al. Comparative Genomic Analysis of Citrobacter and Key Genes Essential for the Pathogenicity of Citrobacter koseri. Front Microbiol. 2019;10:2774.
  20. Ortiz-Lazo E, Arriagada-Egnen C, Poehls C, Concha-Rogazy M. An Update on the Treatment and Management of Cellulitis. Actualización en el abordaje y manejo de celulitis. Actas Dermosifiliogr (Engl Ed). 2019;110(2):124-130.
  21. Brindle R, Williams OM, Barton E, Featherstone P. Assessment of Antibiotic Treatment of Cellulitis and Erysipelas: A Systematic Review and Meta-analysis. JAMA Dermatol. 2019;155(9):1033-1040.
  22. Bandyopadhyay D. Topical Antibacterials in Dermatology. Indian J Dermatol. 2021;66(2):117-125.
  23. Featherstone P, Brindle R, Williams OM. Acute management of cellulitis: A review. Acute Med. 2019;18(2):112-119.

How to Cite

Sari, L. G. M. P., Fatmawati, N. N. D., Praharsini, I. G. A. A., & Giantoro, M. (2022). Colonization of Citrobacter koseri and Streptococcus agalactiae in a case of cellulitis cruris dextra et sinistra. Intisari Sains Medis, 13(2), 426–430. https://doi.org/10.15562/ism.v13i2.1326

HTML
0

Total
0

Share

Search Panel

Luh Gede Melia Puspita Sari
Google Scholar
Pubmed
ISM Journal


Ni Nengah Dwi Fatmawati
Google Scholar
Pubmed
ISM Journal


I Gusti Ayu Agung Praharsini
Google Scholar
Pubmed
ISM Journal


Marvin Giantoro
Google Scholar
Pubmed
ISM Journal